HR 9421 119th Congress
To prohibit a REMS-certified provider from prescribing mifepristone without an in-person visit and a medical license in the State in which the patient resides, and for other purposes.
Latest Action
Referred to the House Committee on Energy and Commerce.
Sponsors
![Rep. Biggs, Sheri [R-SC-3]](https://bioguide.congress.gov/bioguide/photo/B/B001325.jpg)
Actions
2026-06-24T00:00:00
Referred to the House Committee on Energy and Commerce.
2026-06-24T00:00:00
Introduced in House
2026-06-24T00:00:00
Introduced in House
Policy Areas
Health
Track this bill on CivicBeacon
Get push notifications when this bill is updated, contact your reps, and take action.
